Steven L. Chang, MD, MS, Named Section Chief of Urologic Oncology

Dr. Chang will lead the newly formed Section of Urologic Oncology within the Division of Urology in the Department of Surgery at Brigham Health.

Dr. Steven Chang is an associate surgeon at Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center and is an assistant professor of surgery at Harvard Medical School.

Dr. Chang received his medical degree from Columbia University, College of Physicians and Surgeons, and completed a urology residency as well as a urologic oncology fellowship at Stanford University Medical Center. During his fellowship training, Dr. Chang earned a Master of Science in Health Services Research from the Department of Health Research and Policy at Stanford University Medical School. He is board certified in urology.

Dr. Chang cares for patients with urologic cancers, using minimally invasive surgical approaches with laparoscopy and robotics. He is particularly interested in the management of kidney cancer and has established collaborations with medical oncologists at Dana-Farber/Brigham and Women’s Cancer Center and interventional radiologists at Brigham and Women’s Hospital to treat patients with kidney tumors, ranging from incidentally detected small renal masses to metastatic renal cell carcinoma.

Dr. Chang’s research focuses on reducing the overall burden of urologic cancers on the health care system. His clinical specialties include: kidney cancer, prostate cancer, bladder cancer, adrenal cancer, testicular cancer and reconstructive kidney surgery.